Infectoperm (Permethrin)

Permethrin blocks voltage‑gated sodium channels on the nerve cells of parasites. This blockage prolongs depolarization, leading to paralysis and death of the mite or louse while having minimal effect on human nerve cells at the concentrations used in topical therapy.

The exact dose and duration of treatment with Infectoperm are determined by the prescribing healthcare professional based on the specific indication, patient age, weight, and severity of infestation. The prescriber will provide detailed application instructions.

Safety data for permethrin use in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Infectoperm.

To request Infectoperm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Infectoperm (permethrin) belongs to the pyrethroid class, which is widely regarded for its rapid knock‑down effect and low systemic absorption. Compared with older agents such as lindane, permethrin has a better safety profile and is less likely to cause neurotoxicity, making it a preferred first‑line option in many guidelines.

Infectoperm should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Infectoperm is applied topically to clean, dry skin. The prescribed amount is spread evenly over the affected area, left on for the duration specified by the prescriber, and then washed off as directed. Avoid contact with eyes, mouth, and mucous membranes.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and systemic toxicity that may present with neurological symptoms. Patients should seek immediate medical attention if they experience widespread rash, swelling, difficulty breathing, or neurological signs.

Infectoperm should not be used on infants younger than two months, on severely inflamed or broken skin, or in individuals with a known hypersensitivity to permethrin or any component of the formulation. Patients with a history of severe skin reactions should consult a healthcare professional before use.